Every Weight Loss Medication Available in the UK
An overview of UK weight loss medicines: orlistat, liraglutide, semaglutide, tirzepatide, the new GLP-1 tablets and others, with licence and NICE status.
13 min read
Medications guides
Medications Medications Foundayo (Orforglipron): The Small-Molecule GLP-1 Tablet Explained
Foundayo (orforglipron) explained: how the small-molecule GLP-1 tablet works, UK licensing, doses, ATTAIN trial results, side effects and key interactions.
13 min read
Medications How Mounjaro Works: GIP and GLP-1 Explained
A plain-English explanation of how Mounjaro (tirzepatide) works on GIP and GLP-1 receptors to reduce appetite, slow digestion and improve blood sugar.
12 min read
Medications How Wegovy Works: Semaglutide and Appetite Explained
How Wegovy (semaglutide) works: the GLP-1 hormone, its effects on the brain, stomach and pancreas, why it reduces appetite and what happens when you stop.
12 min read
Medications Mounjaro in the UK: The Complete Guide to Tirzepatide for Weight Loss
An evidence-based guide to Mounjaro (tirzepatide) in the UK: how it works, who it is licensed for, trial results, side effects, NHS and private access.
13 min read
Medications Oral GLP-1 Medications in the UK: The Complete Guide
Wegovy tablets, Foundayo and Rybelsus explained: how oral GLP-1 medicines work, UK licensing, trial results, how to take them and who they may suit.
13 min read
Medications Oral Semaglutide: How the Wegovy Tablet Works
How Wegovy tablets (oral semaglutide) work, how to take them, the 1.5mg to 25mg dose schedule, OASIS trial results, side effects and UK status.
12 min read
Medications Rybelsus and Weight Loss: Why It's Licensed for Diabetes, Not Obesity
Rybelsus is oral semaglutide licensed for type 2 diabetes. Why it is not a UK weight-loss medicine, how it differs from Wegovy tablets, and the evidence.
13 min read
Medications Semaglutide in the UK: Wegovy, Ozempic and Rybelsus Explained
Semaglutide is sold in the UK as Wegovy, Ozempic and Rybelsus. How each is licensed, dosed and regulated, and why they are not interchangeable.
12 min read
Medications The GLP-1 Pipeline: Retatrutide, CagriSema, Amycretin and What Comes Next
An evidence-based look at new weight loss drugs in development, including retatrutide, CagriSema and amycretin: how they work, trial results and UK status.
13 min read
Medications Tirzepatide in the UK: The Science Behind Mounjaro
What tirzepatide is, how a dual GIP/GLP-1 agonist works, what the SURMOUNT and SURPASS trials found, and how it is licensed and used in the UK.
14 min read
Medications Wegovy in the UK: The Complete Guide to Semaglutide for Weight Loss
A UK guide to Wegovy (semaglutide): how it works, who it is licensed for, doses including 7.2mg, trial results, side effects, NHS access and costs.
13 min read
Medications Weight Loss Tablets in the UK: What's Licensed and What the Evidence Says
Which weight loss tablets are licensed in the UK, from orlistat to Wegovy tablets and Foundayo, what trials show, and how to avoid unsafe slimming pills.
12 min read
Medications What Are GLP-1 Medications? A Plain-English Guide
A plain-English guide to GLP-1 medicines: what GLP-1 is, how Mounjaro, Wegovy and the new tablets work, their UK licences and side effects.
13 min read